Short answer · Medically reviewed summary · Last updated: 2026-04-07
Coats disease is primarily known as exudative retinitis or retinitis exudativa, though it is most commonly referred to by its eponymous name in modern clinical practice. Historical and Alternative Nomenclature The condition was first described by George Coats in 1908, leading to the widely accepted eponymous name, Coats disease. Historically, medical literature may refer to it as retinitis exudativa or Coats' retinopathy.
1 people with Coats Disease have shared their first-person experience on this question at DiseaseMaps.
Coats disease is primarily known as exudative retinitis or retinitis exudativa, though it is most commonly referred to by its eponymous name in modern clinical practice.
The condition was first described by George Coats in 1908, leading to the widely accepted eponymous name, Coats disease. Historically, medical literature may refer to it as retinitis exudativa or Coats' retinopathy. Because the condition involves the abnormal development of blood vessels in the retina, it is occasionally categorized under the broader umbrella of idiopathic retinal telangiectasia.
In older medical records or international texts, you may encounter the following terms:
In major medical databases, the terminology is standardized to facilitate global research and patient care. According to Orphanet, the official classification is listed under "Coats disease" (ORPHA:193). The OMIM (Online Mendelian Inheritance in Man) database catalogs it under the entry #300210, emphasizing its idiopathic nature. In the ICD-10 (International Classification of Diseases), it is often coded under H35.0, reflecting its status as a background retinopathy.
The variety of names for Coats disease stems from early 20th-century attempts to classify the condition based on its clinical appearance—specifically the "exudative" (leaking) fluid seen during ophthalmic examinations—rather than its underlying genetic or vascular etiology. As our understanding of retinal vascular biology has evolved, the term Coats disease has become the preferred nomenclature among ophthalmologists and vitreoretinal specialists worldwide. This consistency helps ensure that patients, caregivers, and researchers remain aligned when discussing diagnostic criteria and treatment pathways for Coats disease.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your ophthalmologist or other qualified health provider with any questions you may have regarding a medical condition.